Review
BibTex RIS Cite

PKOS'da Ovarian Drillinge Güncel Bakış

Year 2023, Volume: 20 Issue: 4, 2031 - 2036, 31.12.2023

Nafiye Yılmaz Cavide Ali Algan Ruhat Karakuş

https://doi.org/10.38136/jgon.1094678

Abstract

Polikistik over sendromu, üreme çağındaki kadınların yaklaşık 5–18%’ini etkileyen en yaygın endokrin problemdir ve anovulasyona bağlı infertiliteye yol açabilir. İnfertiliteye yönelik tedavilerde yaşam tarzı değişikliği ve kilo verme ilk basamak yaklaşımdır. Medikal tedavilerde birinci basamak tedavi yaklaşımı Klomifen Sitrat (KS) ile ovulasyon indüksiyonudur (Oİ), son yıllarda aromataz inhibitörlerinin (Aİ) de birinci basamak tedavide olmasına yönelik öneriler ve bulgular bildirilmektedir. Tekrarlı KS kullanımına rağmen % 25 oranda KS'a yanıt alınamayabilir, bu hasta grubu KS dirençli PKOS grup olarak tanımlanır. Bu hastalarda ovulasyon oranlarını artırmaya yönelik ikinci basamak tedavi yaklaşımları uygulanır. İkinci basamak tedavi yaklaşımları Gonadotropin ile Oİ olabileceği gibi Ovarian Drilling (OD) gibi cerrahi tedaviler de olabilir. Bu makalede OD konusundaki geçmiş ve güncel uygulamalar sunulacaktır.

Keywords

Polikistik over sendromu infertilite ovaryen drilling

References

  • 1.Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89(6):2745–9.
  • 2. Joham AE, Boyle JA, Ranasinha S, Zoungas S, Teede HJ. Contraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women’s Health. Hum Reprod Oxf Engl 2014;29(4):802–8. 10
  • 3. Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016; 22(6): 687-708.
  • 4. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod. 2008; 23(3): 462- 477.
  • 5. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004; 19(1): 41-47.
  • 6. Final Report National Institute of Health. Evidence-based Methodology Workshop on Polycystic Ovary Syndrome. Executive summary at https://prevention.nih.gov/sites/default/files/2018-06/ FinalReport.pdf. (3-5 Dec 2012).
  • 7. Final Report National Institute of Health. Evidence-based Methodology Workshop on Polycystic Ovary Syndrome December 3–5, 2012 Executive summary at http://prevention.nih.gov/workshops/2012/pcos/resourc-es.aspx.
  • 8. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 1992; 41: 1257–66.
  • 9. Moran LJ, Brinkworth G, Noakes M, Norman RJ. Eff ects of lifestyle modifi cation in polycystic ovarian syndrome. Reprod Biomed Online 2006; 12: 569–78.
  • 10. Huber-Buchholz MM, Carey DG, Norman RJ. Restoration of reproductive potential by lifestyle modifi cation in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab 1999; 84: 1470–74.
  • 11. Evidence-based guidelines for the assessment and management of polycystic ovary syndrome. Jean Hailes for Women’s Health on behalf of the PCOS Australian Alliance; Melbourne. https:// jeanhailes.org.au/contents/documents/Resources/Tools/PCOS_ evidence based_guideline_for_assessment_and_management_ pcos.pdf. 2015.
  • 12. Amer SA, Smith J, Mahran A, Fox P, Fakis A. Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Hum Reprod. 2017; 32(8): 1631-1638.
  • 13. Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, et al. american association of clinical endocrinologists, american college of endocrinology, and androgen excess and pcos society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome--part 2. Endocr Pract. 2015; 21(12): 1415-1426.
  • 14. Imani B, Eijkemans MJ, Te Velde ER, Habbema JD, Fauser BC.Predictors of patients remaining anovulatory during clomiphenecitrate induction of ovulation in normogonadotropicoligomenorrheic infertility. J Clin Endocrinol Metab 1998; 83:2361–2365. 11
  • 15. Balen AH, Morley LC, Misso M, et al. The management of anovulatory infertility inwomen with polycystic ovary syndrome: an analysis of the evidence to support thedevelopment of global who guidance. Hum Reprod Update 2016;22:687–708.
  • 16. Imani B, Eijkemans MJC, te Velde ER, et al. A nomogram to predict the probabilityof live birth after clomiphene citrate induction of ovulation in normogonadotropicoligoamenorrheic infertility. Fertil Steril 2002;77:91–7.
  • 17.Nahuis MJ, Oude Lohuis EJ, Bayram N, et al. Pregnancy complications and metabolicdisease in women with clomiphene citrate-resistantanovulation randomized toreceive laparoscopic electrocautery of the ovaries or ovulation induction withgonadotropins: a 10-yearfollow-up.Fertil Steril 2014;101:270–4.
  • 18. Gjönnaess H , Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope. Fertil. Steril. 1984, 41, 20–25.
  • 19. Stein, I.F.; Leventhal, M.L. Amenorrhea associated with bilateral polycystic ovaries. Am. J. Obstet. Gynecol. 1935, 29, 181–191.
  • 20. Abu Hashim, H.; Foda, O.; El Rakhawy, M. Unilateral or bilateral laparoscopic ovarian drilling in polycystic ovary syndrome: A meta-analysis of randomized trials. Arch. Gynecol. Obstet. 2018, 297, 859–870
  • 21. Yu, Y.; Fang, L.; Zhang, R.; He, J.; Xiong, Y.; Guo, X.; Du, Q.; Huang, Y.; Sun, Y. Comparative effectiveness of 9 ovulation-induction therapies in patients with clomiphene citrate-resistant polycystic ovary syndrome: A network meta-analysis. Sci. Rep. 2017, 7, 3812.
  • 22. Sun, H.D.; Horng, H.C.; Liu, C.H.; Hsiao, S.M.; Chen, Y.J.; Chang, W.H.; Wang, P.H. Comparison of single-port and three-port laparoscopic salpingectomy in the management of tubal pregnancy. J. Chin. Med. Assoc. 2018, 81, 469–474.
  • 23. Yang, J.; Song, Y.J.; Na, Y.J.; Kim, H.G. Two-port myomectomy using bag-contained manual morcellation: A comparison with three-port myomectomy using power morcellation. Taiwan J. Obstet. Gynecol. 2019, 58, 423–427.
  • 24. Lee, Y.L.; Hsu, T.F.; Jiang, L.Y.; Chao, H.T.; Wang, P.H.; Chen, Y.J. Transvaginal natural orifice transluminal endoscopic surgery for female-to-male transgender men. J. Minim. Invasive Gynecol. 2019, 26, 135–142.
  • 25. Amer, S.A.; Li, T.C.; Cooke, I.D. A prospective dose-finding study of the amount of thermal energy required for laparoscopic ovarian diathermy. Hum. Reprod. 2003, 18, 1693–1698.
  • 26. Balen, A.H.; Morley, L.C.; Misso, M.; Franks, S.; Legro, R.S.; Wijeyaratne, C.N.; Stener- Victorin, E.; Fauser, B.C.; Norman, R.J.; Teede, H. The management of anovulatory infertility in women with polycystic ovary syndrome: An analysis of the evidence to support the development of global WHO guidance. Hum. Reprod. Update 2016, 22, 687–708. 12
  • 27. Tsai, H.W.; Wang, P.H.; Yen, M.S.; Chao, K.C.; Hsu, T.F.; Chen, Y.J. Prevention of postlaparoscopic shoulder and upper abdominal pain: A randomized controlled trial. Obstet. Gynecol. 2013, 121, 526–531.
  • 28. Tsai, H.W.; Chen, Y.J.; Ho, C.M.; Hseu, S.S.; Chao, K.C.; Tsai, S.K.; Wang, P.H. Maneuvers to decrease laparoscopy-induced shoulder and upper abdominal pain: A randomized controlled study. Arch. Surg. 2011, 146, 1360–1366.
  • 29. Hafizi, L.; Amirian, M.; Davoudi, Y.; Jaafari, M.; Ghasemi, G.H. Comparison of laparoscopic ovarian drilling success between two standard and dose-adjusted methods in polycystic ovary syndrome: A randomized clinical trial. Int. J. Fertil. Steril. 2020, 13, 282–288.
  • 30.Gordts, S., Campo, R., Rombauts, L., Brosens, I., 1998. Transvaginal hydrolaparoscopy as an outpatient procedure for infertility investigation. Hum. Reprod. 13, 99–103.
  • 31.Watrelot, A., Dreyfus, J.M., Andine, J.P., 1999. Evaluation of the performance of fertiloscopy in 160 consecutive infertile patients with no obvious pathology. Hum. Reprod. 14, 707–711.
  • 32.Amer, S.A., Li, T.C., Cooke, I.D., 2003a. A prospective dose-finding study of the amount of thermal energy required for laparoscopic ovarian diathermy. Hum. Reprod. 18, 1693–1698.
  • 33.Fernandez, H., Faivre, E., Gervaise, A., Deffieux, X., 2010. Laparoscopic ovarian drilling using a 5-French bipolar energy probe. Fertil. Steril. 94, 740–741.
  • 34.Xu et al. Reproductive Biology and Endocrinology (2020) 18:7 Reproductive Biology and Endocrinology volume 18, Article number: 7 (2020) Available from : https://rbej.biomedcentral.com/articles/10.1186/s12958-019-0559-7
  • 35.Kaya, H., Sezik, M., Ozkaya, O., 2005. Evaluation of a new surgical approach for the treatment of clomiphene citrate-resistant infertility in polycystic ovary syndrome: laparoscopic ovarian.
  • 36.Dabirashrafi, H., 1989. Complications of laparoscopic ovarian cauterization. Fertil. Steril. 52, 878–879.
  • 37. El-Sheikhah, A., Aboulghar, M., Read, R., El-Hendawi, E., 2004. The extent of ovarian damage produced by ovarian cauterisation in the human. J. Obstet. Gynaecol. 24, 664–666.
  • 38.Amer, S.A., Li, T.C., Cooke, I.D., 2003. Repeated laparoscopic ovarian diathermy is effective in women with anovulatory infertility due to polycystic ovary syndrome. Fertil. Steril. 79, 1211–1215 14
  • 39.Dabirashrafi, H., Mohamad, K., Behjatnia, Y., Moghadami-Tabrizi, N., 1991. Adhesion formation after ovarian electrocauterization on patients with polycystic ovarian syndrome. Fertil. Steril. 55, 1200–1201.
  • 40.Malkawi, H.Y., Qublan, H.S., 2005. Laparoscopic ovarian drilling in the treatment of polycystic ovary syndrome: how many punctures per ovary are needed to improve the reproductive outcome? J. Obstet. Gynaecol. Res. 31, 115–119.
  • 41.Api, M., 2009. Is ovarian reserve diminished after laparoscopic ovarian drilling? Gynecol. Endocrinol. 25, 159–165.
  • 42.Farquhar, C.M.;Williamson, K.; Gudex, G.; Johnson, N.P.; Garland, J.; Sadler, L. A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate-resistant polycystic ovary syndrome. Fertil. Steril. 2002, 78, 404–411.
  • 43.Seow, K.M.; Juan, C.C.; Hwang, J.L.; Ho, L.T. Laparoscopic surgery in polycystic ovary syndrome:Reproductive and metabolic e_ects. Semin. Reprod. Med. 2008, 26, 101–110.
  • 44. Seow, K.M.; Lee,W.L.;Wang, P.H. A chellange in the management of women with polycystic ovary syndrome. Taiwan J. Obstet. Gynecol. 2016, 55, 157–158.
  • 45. Seow, K.M.; Juan, C.C.; Ho, L.T.; Hsu, Y.P.; Lin, Y.H.; Huang, L.W.; Hwang, J.L. Adipocyte resistin mRNA levels are down-regulated by laparoscopic ovarian electrocautery in both obese and lean women with polycystic ovary syndrome. Hum. Reprod. 2007, 22, 1100–1106.
  • 46. Flyckt, R.L.; Goldberg, J.M. Laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome. Semin. Reprod. Med. 2011, 29, 138–146.
  • 47.Amer, S.A.; Shamy, T.T.E.; James, C.; Yosef, A.H.; Mohamed, A.A. The impact of laparoscopic ovarian drilling on AMH and ovarian reserve: A meta-analysis. Reproduction 2017, 154, R13–R21.
  • 48. . Sunj M, Canic T, Baldani DP, Tandara M, Jeroncic A, Palada I. Does unilateral laparoscopic diathermy adjusted to ovarian volume increase the chances of ovulation in women with polycystic ovary syndrome? Hum Reprod Oxf Engl 2013;28(9):2417–24.
  • 49. Zhang, J.; Tang, L.; Kong, L.; Wu, T.; Xu, L.; Pan, X.; Liu, G.J. Ultrasound-guided transvaginal ovarian needle drilling for clomiphene-resistant polycystic ovarian syndrome in subfertile women. Cochrane Database Syst. Rev. 2019, 7, CD008583.
  • 50. Salah, I.M. O_ce microlaparoscopic ovarian drilling (OMLOD) versus conventional laparoscopic ovarian drilling (LOD) for women with polycystic ovary syndrome. Arch. Gynecol. Obstet. 2013, 287, 361–367.
  • 51. Flyckt, R.L.; Goldberg, J.M. Laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome. Semin. Reprod. Med. 2011, 29, 138–146. 15
  • 52. Seckin, B.; Tokmak, A.; Yumusak, O.H. The role of anti-Mullerian homrone in predeiction of pregnancy in young and older women with unexplained infertility undergoing intrauterine insemination. J. Chin. Med. Assoc. 2019, 82, 300–304.
  • 53. Ahmed, N.; Batarfi, A.A.; Bajouh, O.S.; Bakhashab, S. Serum anti-Müllerian hormone in the diagnosis of polycystic ovary syndrome in association with clinical symptoms. Diagnostics 2019, 9, 136.
  • 54. Giampaolino, P.; Morra, I.; De Rosa, N.; Cagnacci, A.; Pellicano, M.; Di Carlo, C.; Nappi, C.; Bifulco, G. Impact of transvaginal hydrolaparoscopy ovarian drilling on ovarian stromal blood flow and ovarian volume in clomiphene citrate-resistant PCOS patients: A case-control study. Gynecol. Endocrinol. 2017, 33, 690–693.
  • 55. Seyam, E.; Hefzy, E. Tumor necrosis factor alpha versus LH and androstendione as a reliable predictor of spontaneous ovulation after laparoscopic ovarian drilling for women with clomiphene citrate resistance polycystic ovarian disease. Eur. J. Obstet. Gynecol. Reprod. Biol. 2018, 222, 126–133.
  • 56. Abuelghar, W.M.; Bayoumy, H.A.; Ellaithy, M.I.; Khalil, M.S. Women with clomiphene citrate resistant polycystic ovarian disease: Predictors of spontaneous ovulation after laparoscopic ovarian drilling. Eur. J. Obstet. Gynecol. Reprod. Biol. 2014, 175, 178–185.
  • 57. wu, S.A.; Gopalan, V.; Li, T.C.; Ledger, W.L.; Cooke, I.D. Long term follow-up of patients with polycystic ovarian syndrome after laparoscopic ovarian drilling: Clinical outcome. Hum. Reprod. 2002, 17, 2035–2042.
  • 58.Nasrhim H. Predictors of success of laparoscopic ovarian drilling in women with polycystic ovary syndrome: an evidence-based approach. Arch Gynecol Obstet 2015;291(1):11–8.
  • 59. Amer SaK, Li TC, Ledger WL. Ovulation induction using laparoscopic ovarian drilling in women with polycystic ovarian syndrome: predictors of success. Hum Reprod Oxf Engl 2004;19(8):1719–24.
  • 60.Elmashad AI. Impact of laparoscopic ovarian drilling on anti-Müllerian hormone levels and ovarian stromal blood flow using three-dimensional power Doppler in women with anovulatory polycystic ovary syndrome. Fertil Steril 2011;95(7)2342–6 2346.e1. 16
  • 61 Sunj M, Canic T, Baldani DP, Tandara M, Jeroncic A, Palada I. Does unilateral laparoscopic diathermy adjusted to ovarian volume increase the chances of ovulation in women with polycystic ovary syndrome? Hum Reprod Oxf Engl 2013;28(9):2417–24.
  • 62. van Wely M, Bayram N, van der Veen F, Bossuyt PMM. Predictors for treatment failure after laparoscopic electrocautery of the ovaries in women with clomiphene citrate resistant polycystic ovary syndrome. Hum Reprod Oxf Engl 2005;20(4):900–5.
  • 63. Zakherah MS, Kamal MM, Hamed HO. Laparoscopic ovarian drilling in polycystic ovary syndrome: efficacy of adjusted thermal dose based on ovarian volume. Fertil Steril (2011) 95:1115–8.
  • 64. Naether, O.G.; Baukloh, V.; Fischer, R.; Kowalczyk, T. Long-term follow-up in 206 infertility patients with polycystic ovarian syndrome after laparoscopic electrocautery of the ovarian surface. Hum. Reprod. 1994, 9, 2342–2349.
  • 65. Ferraretti, A.P.; Gianaroli, L.; Magli, M.C.; Iammarrone, E.; Feliciani, E.; Fortini, D. Transvaginal ovarianndrilling: A new surgical treatment for improving the clinical outcome of assisted reproductive Technologies in patients with polycystic ovary syndrome. Fertil. Steril. 2001, 76, 812–816.
  • 66. Debras, E.; Fernandez, H.; Neveu, M.E.; De_eux, X.; Capmas, P. Ovarian drilling in polycystic ovary syndrome: Long term pregnancy rate. Eur. J. Obstet. Gynecol. Reprod. Biol. X 2019, 4, 100093.

Current Approach in Ovarian Drilling in PCOS

Year 2023, Volume: 20 Issue: 4, 2031 - 2036, 31.12.2023

Nafiye Yılmaz Cavide Ali Algan Ruhat Karakuş

https://doi.org/10.38136/jgon.1094678

Abstract

Polycystic ovary syndrome is the most common endocrine problem affecting about 5-18% of women of reproductive age and can lead to infertility due to anovulation. Lifestyle change and weight loss are the first-line approaches in infertility treatment. The first-line treatment approach in medical treatments is ovulation induction (OI) with Clomiphene Citrate (CC), and in recent years, recommendations and findings have been reported for the use of aromatase inhibitors (AI) in first-line treatment. Despite repeated use of CC, there may be no response to CC at a rate of 25%, this group of patients is defined as a CC-resistant PCOS group. In these patients, second-line treatment approaches are applied to increase ovulation rates. Second-line treatment approaches can be OI with Gonadotropin, as well as surgical treatments such as Ovarian Drilling (OD). In this article, past and current practices on OD will be presented.

Keywords

Polycystic ovary syndrome infertility ovarian drilling

References

  • 1.Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89(6):2745–9.
  • 2. Joham AE, Boyle JA, Ranasinha S, Zoungas S, Teede HJ. Contraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women’s Health. Hum Reprod Oxf Engl 2014;29(4):802–8. 10
  • 3. Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016; 22(6): 687-708.
  • 4. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod. 2008; 23(3): 462- 477.
  • 5. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004; 19(1): 41-47.
  • 6. Final Report National Institute of Health. Evidence-based Methodology Workshop on Polycystic Ovary Syndrome. Executive summary at https://prevention.nih.gov/sites/default/files/2018-06/ FinalReport.pdf. (3-5 Dec 2012).
  • 7. Final Report National Institute of Health. Evidence-based Methodology Workshop on Polycystic Ovary Syndrome December 3–5, 2012 Executive summary at http://prevention.nih.gov/workshops/2012/pcos/resourc-es.aspx.
  • 8. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 1992; 41: 1257–66.
  • 9. Moran LJ, Brinkworth G, Noakes M, Norman RJ. Eff ects of lifestyle modifi cation in polycystic ovarian syndrome. Reprod Biomed Online 2006; 12: 569–78.
  • 10. Huber-Buchholz MM, Carey DG, Norman RJ. Restoration of reproductive potential by lifestyle modifi cation in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab 1999; 84: 1470–74.
  • 11. Evidence-based guidelines for the assessment and management of polycystic ovary syndrome. Jean Hailes for Women’s Health on behalf of the PCOS Australian Alliance; Melbourne. https:// jeanhailes.org.au/contents/documents/Resources/Tools/PCOS_ evidence based_guideline_for_assessment_and_management_ pcos.pdf. 2015.
  • 12. Amer SA, Smith J, Mahran A, Fox P, Fakis A. Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Hum Reprod. 2017; 32(8): 1631-1638.
  • 13. Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, et al. american association of clinical endocrinologists, american college of endocrinology, and androgen excess and pcos society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome--part 2. Endocr Pract. 2015; 21(12): 1415-1426.
  • 14. Imani B, Eijkemans MJ, Te Velde ER, Habbema JD, Fauser BC.Predictors of patients remaining anovulatory during clomiphenecitrate induction of ovulation in normogonadotropicoligomenorrheic infertility. J Clin Endocrinol Metab 1998; 83:2361–2365. 11
  • 15. Balen AH, Morley LC, Misso M, et al. The management of anovulatory infertility inwomen with polycystic ovary syndrome: an analysis of the evidence to support thedevelopment of global who guidance. Hum Reprod Update 2016;22:687–708.
  • 16. Imani B, Eijkemans MJC, te Velde ER, et al. A nomogram to predict the probabilityof live birth after clomiphene citrate induction of ovulation in normogonadotropicoligoamenorrheic infertility. Fertil Steril 2002;77:91–7.
  • 17.Nahuis MJ, Oude Lohuis EJ, Bayram N, et al. Pregnancy complications and metabolicdisease in women with clomiphene citrate-resistantanovulation randomized toreceive laparoscopic electrocautery of the ovaries or ovulation induction withgonadotropins: a 10-yearfollow-up.Fertil Steril 2014;101:270–4.
  • 18. Gjönnaess H , Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope. Fertil. Steril. 1984, 41, 20–25.
  • 19. Stein, I.F.; Leventhal, M.L. Amenorrhea associated with bilateral polycystic ovaries. Am. J. Obstet. Gynecol. 1935, 29, 181–191.
  • 20. Abu Hashim, H.; Foda, O.; El Rakhawy, M. Unilateral or bilateral laparoscopic ovarian drilling in polycystic ovary syndrome: A meta-analysis of randomized trials. Arch. Gynecol. Obstet. 2018, 297, 859–870
  • 21. Yu, Y.; Fang, L.; Zhang, R.; He, J.; Xiong, Y.; Guo, X.; Du, Q.; Huang, Y.; Sun, Y. Comparative effectiveness of 9 ovulation-induction therapies in patients with clomiphene citrate-resistant polycystic ovary syndrome: A network meta-analysis. Sci. Rep. 2017, 7, 3812.
  • 22. Sun, H.D.; Horng, H.C.; Liu, C.H.; Hsiao, S.M.; Chen, Y.J.; Chang, W.H.; Wang, P.H. Comparison of single-port and three-port laparoscopic salpingectomy in the management of tubal pregnancy. J. Chin. Med. Assoc. 2018, 81, 469–474.
  • 23. Yang, J.; Song, Y.J.; Na, Y.J.; Kim, H.G. Two-port myomectomy using bag-contained manual morcellation: A comparison with three-port myomectomy using power morcellation. Taiwan J. Obstet. Gynecol. 2019, 58, 423–427.
  • 24. Lee, Y.L.; Hsu, T.F.; Jiang, L.Y.; Chao, H.T.; Wang, P.H.; Chen, Y.J. Transvaginal natural orifice transluminal endoscopic surgery for female-to-male transgender men. J. Minim. Invasive Gynecol. 2019, 26, 135–142.
  • 25. Amer, S.A.; Li, T.C.; Cooke, I.D. A prospective dose-finding study of the amount of thermal energy required for laparoscopic ovarian diathermy. Hum. Reprod. 2003, 18, 1693–1698.
  • 26. Balen, A.H.; Morley, L.C.; Misso, M.; Franks, S.; Legro, R.S.; Wijeyaratne, C.N.; Stener- Victorin, E.; Fauser, B.C.; Norman, R.J.; Teede, H. The management of anovulatory infertility in women with polycystic ovary syndrome: An analysis of the evidence to support the development of global WHO guidance. Hum. Reprod. Update 2016, 22, 687–708. 12
  • 27. Tsai, H.W.; Wang, P.H.; Yen, M.S.; Chao, K.C.; Hsu, T.F.; Chen, Y.J. Prevention of postlaparoscopic shoulder and upper abdominal pain: A randomized controlled trial. Obstet. Gynecol. 2013, 121, 526–531.
  • 28. Tsai, H.W.; Chen, Y.J.; Ho, C.M.; Hseu, S.S.; Chao, K.C.; Tsai, S.K.; Wang, P.H. Maneuvers to decrease laparoscopy-induced shoulder and upper abdominal pain: A randomized controlled study. Arch. Surg. 2011, 146, 1360–1366.
  • 29. Hafizi, L.; Amirian, M.; Davoudi, Y.; Jaafari, M.; Ghasemi, G.H. Comparison of laparoscopic ovarian drilling success between two standard and dose-adjusted methods in polycystic ovary syndrome: A randomized clinical trial. Int. J. Fertil. Steril. 2020, 13, 282–288.
  • 30.Gordts, S., Campo, R., Rombauts, L., Brosens, I., 1998. Transvaginal hydrolaparoscopy as an outpatient procedure for infertility investigation. Hum. Reprod. 13, 99–103.
  • 31.Watrelot, A., Dreyfus, J.M., Andine, J.P., 1999. Evaluation of the performance of fertiloscopy in 160 consecutive infertile patients with no obvious pathology. Hum. Reprod. 14, 707–711.
  • 32.Amer, S.A., Li, T.C., Cooke, I.D., 2003a. A prospective dose-finding study of the amount of thermal energy required for laparoscopic ovarian diathermy. Hum. Reprod. 18, 1693–1698.
  • 33.Fernandez, H., Faivre, E., Gervaise, A., Deffieux, X., 2010. Laparoscopic ovarian drilling using a 5-French bipolar energy probe. Fertil. Steril. 94, 740–741.
  • 34.Xu et al. Reproductive Biology and Endocrinology (2020) 18:7 Reproductive Biology and Endocrinology volume 18, Article number: 7 (2020) Available from : https://rbej.biomedcentral.com/articles/10.1186/s12958-019-0559-7
  • 35.Kaya, H., Sezik, M., Ozkaya, O., 2005. Evaluation of a new surgical approach for the treatment of clomiphene citrate-resistant infertility in polycystic ovary syndrome: laparoscopic ovarian.
  • 36.Dabirashrafi, H., 1989. Complications of laparoscopic ovarian cauterization. Fertil. Steril. 52, 878–879.
  • 37. El-Sheikhah, A., Aboulghar, M., Read, R., El-Hendawi, E., 2004. The extent of ovarian damage produced by ovarian cauterisation in the human. J. Obstet. Gynaecol. 24, 664–666.
  • 38.Amer, S.A., Li, T.C., Cooke, I.D., 2003. Repeated laparoscopic ovarian diathermy is effective in women with anovulatory infertility due to polycystic ovary syndrome. Fertil. Steril. 79, 1211–1215 14
  • 39.Dabirashrafi, H., Mohamad, K., Behjatnia, Y., Moghadami-Tabrizi, N., 1991. Adhesion formation after ovarian electrocauterization on patients with polycystic ovarian syndrome. Fertil. Steril. 55, 1200–1201.
  • 40.Malkawi, H.Y., Qublan, H.S., 2005. Laparoscopic ovarian drilling in the treatment of polycystic ovary syndrome: how many punctures per ovary are needed to improve the reproductive outcome? J. Obstet. Gynaecol. Res. 31, 115–119.
  • 41.Api, M., 2009. Is ovarian reserve diminished after laparoscopic ovarian drilling? Gynecol. Endocrinol. 25, 159–165.
  • 42.Farquhar, C.M.;Williamson, K.; Gudex, G.; Johnson, N.P.; Garland, J.; Sadler, L. A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate-resistant polycystic ovary syndrome. Fertil. Steril. 2002, 78, 404–411.
  • 43.Seow, K.M.; Juan, C.C.; Hwang, J.L.; Ho, L.T. Laparoscopic surgery in polycystic ovary syndrome:Reproductive and metabolic e_ects. Semin. Reprod. Med. 2008, 26, 101–110.
  • 44. Seow, K.M.; Lee,W.L.;Wang, P.H. A chellange in the management of women with polycystic ovary syndrome. Taiwan J. Obstet. Gynecol. 2016, 55, 157–158.
  • 45. Seow, K.M.; Juan, C.C.; Ho, L.T.; Hsu, Y.P.; Lin, Y.H.; Huang, L.W.; Hwang, J.L. Adipocyte resistin mRNA levels are down-regulated by laparoscopic ovarian electrocautery in both obese and lean women with polycystic ovary syndrome. Hum. Reprod. 2007, 22, 1100–1106.
  • 46. Flyckt, R.L.; Goldberg, J.M. Laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome. Semin. Reprod. Med. 2011, 29, 138–146.
  • 47.Amer, S.A.; Shamy, T.T.E.; James, C.; Yosef, A.H.; Mohamed, A.A. The impact of laparoscopic ovarian drilling on AMH and ovarian reserve: A meta-analysis. Reproduction 2017, 154, R13–R21.
  • 48. . Sunj M, Canic T, Baldani DP, Tandara M, Jeroncic A, Palada I. Does unilateral laparoscopic diathermy adjusted to ovarian volume increase the chances of ovulation in women with polycystic ovary syndrome? Hum Reprod Oxf Engl 2013;28(9):2417–24.
  • 49. Zhang, J.; Tang, L.; Kong, L.; Wu, T.; Xu, L.; Pan, X.; Liu, G.J. Ultrasound-guided transvaginal ovarian needle drilling for clomiphene-resistant polycystic ovarian syndrome in subfertile women. Cochrane Database Syst. Rev. 2019, 7, CD008583.
  • 50. Salah, I.M. O_ce microlaparoscopic ovarian drilling (OMLOD) versus conventional laparoscopic ovarian drilling (LOD) for women with polycystic ovary syndrome. Arch. Gynecol. Obstet. 2013, 287, 361–367.
  • 51. Flyckt, R.L.; Goldberg, J.M. Laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome. Semin. Reprod. Med. 2011, 29, 138–146. 15
  • 52. Seckin, B.; Tokmak, A.; Yumusak, O.H. The role of anti-Mullerian homrone in predeiction of pregnancy in young and older women with unexplained infertility undergoing intrauterine insemination. J. Chin. Med. Assoc. 2019, 82, 300–304.
  • 53. Ahmed, N.; Batarfi, A.A.; Bajouh, O.S.; Bakhashab, S. Serum anti-Müllerian hormone in the diagnosis of polycystic ovary syndrome in association with clinical symptoms. Diagnostics 2019, 9, 136.
  • 54. Giampaolino, P.; Morra, I.; De Rosa, N.; Cagnacci, A.; Pellicano, M.; Di Carlo, C.; Nappi, C.; Bifulco, G. Impact of transvaginal hydrolaparoscopy ovarian drilling on ovarian stromal blood flow and ovarian volume in clomiphene citrate-resistant PCOS patients: A case-control study. Gynecol. Endocrinol. 2017, 33, 690–693.
  • 55. Seyam, E.; Hefzy, E. Tumor necrosis factor alpha versus LH and androstendione as a reliable predictor of spontaneous ovulation after laparoscopic ovarian drilling for women with clomiphene citrate resistance polycystic ovarian disease. Eur. J. Obstet. Gynecol. Reprod. Biol. 2018, 222, 126–133.
  • 56. Abuelghar, W.M.; Bayoumy, H.A.; Ellaithy, M.I.; Khalil, M.S. Women with clomiphene citrate resistant polycystic ovarian disease: Predictors of spontaneous ovulation after laparoscopic ovarian drilling. Eur. J. Obstet. Gynecol. Reprod. Biol. 2014, 175, 178–185.
  • 57. wu, S.A.; Gopalan, V.; Li, T.C.; Ledger, W.L.; Cooke, I.D. Long term follow-up of patients with polycystic ovarian syndrome after laparoscopic ovarian drilling: Clinical outcome. Hum. Reprod. 2002, 17, 2035–2042.
  • 58.Nasrhim H. Predictors of success of laparoscopic ovarian drilling in women with polycystic ovary syndrome: an evidence-based approach. Arch Gynecol Obstet 2015;291(1):11–8.
  • 59. Amer SaK, Li TC, Ledger WL. Ovulation induction using laparoscopic ovarian drilling in women with polycystic ovarian syndrome: predictors of success. Hum Reprod Oxf Engl 2004;19(8):1719–24.
  • 60.Elmashad AI. Impact of laparoscopic ovarian drilling on anti-Müllerian hormone levels and ovarian stromal blood flow using three-dimensional power Doppler in women with anovulatory polycystic ovary syndrome. Fertil Steril 2011;95(7)2342–6 2346.e1. 16
  • 61 Sunj M, Canic T, Baldani DP, Tandara M, Jeroncic A, Palada I. Does unilateral laparoscopic diathermy adjusted to ovarian volume increase the chances of ovulation in women with polycystic ovary syndrome? Hum Reprod Oxf Engl 2013;28(9):2417–24.
  • 62. van Wely M, Bayram N, van der Veen F, Bossuyt PMM. Predictors for treatment failure after laparoscopic electrocautery of the ovaries in women with clomiphene citrate resistant polycystic ovary syndrome. Hum Reprod Oxf Engl 2005;20(4):900–5.
  • 63. Zakherah MS, Kamal MM, Hamed HO. Laparoscopic ovarian drilling in polycystic ovary syndrome: efficacy of adjusted thermal dose based on ovarian volume. Fertil Steril (2011) 95:1115–8.
  • 64. Naether, O.G.; Baukloh, V.; Fischer, R.; Kowalczyk, T. Long-term follow-up in 206 infertility patients with polycystic ovarian syndrome after laparoscopic electrocautery of the ovarian surface. Hum. Reprod. 1994, 9, 2342–2349.
  • 65. Ferraretti, A.P.; Gianaroli, L.; Magli, M.C.; Iammarrone, E.; Feliciani, E.; Fortini, D. Transvaginal ovarianndrilling: A new surgical treatment for improving the clinical outcome of assisted reproductive Technologies in patients with polycystic ovary syndrome. Fertil. Steril. 2001, 76, 812–816.
  • 66. Debras, E.; Fernandez, H.; Neveu, M.E.; De_eux, X.; Capmas, P. Ovarian drilling in polycystic ovary syndrome: Long term pregnancy rate. Eur. J. Obstet. Gynecol. Reprod. Biol. X 2019, 4, 100093.
There are 66 citations in total.

Details

Primary Language Turkish
Subjects Obstetrics and Gynaecology
Journal Section Review
Authors

Nafiye Yılmaz 0000-0002-4041-297X

Cavide Ali Algan 0000-0001-6188-1516

Ruhat Karakuş 0000-0003-3886-7921

Publication Date December 31, 2023
Submission Date March 28, 2022
Acceptance Date July 23, 2023
Published in Issue Year 2023 Volume: 20 Issue: 4

Cite

Vancouver Yılmaz N, Ali Algan C, Karakuş R. PKOS’da Ovarian Drillinge Güncel Bakış. JGON. 2023;20(4):2031-6.
 Download Cover Image